Abivax S.A.

Healthcare

NASDAQ:ABVX · NASDAQ Global Market

Market Cap $6.33B Beta -0.20 P/E (TTM) -17.6

$96.55 -4.28%

-$4.32 today

52W Low $5.69High $148.83

Vol 1.01M · Avg 1.57M

EPS (TTM)-$4.83

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+1283.24%

Period High

$145.31

Period Low

$5.97

Latest

$96.55

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Jazz Pharmaceuticals plc

NASDAQ:JAZZ

$14.48B

Axsome Therapeutics, Inc.

NASDAQ:AXSM

$13.13B

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

$11.08B

Nuvalent, Inc.

NASDAQ:NUVL

$9.07B

Corcept Therapeutics Incorporated

NASDAQ:CORT

$8.90B

Cytokinetics, Incorporated

NASDAQ:CYTK

$8.73B

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$8.24B

Metsera, Inc.

MTSR

$7.43B

Merus N.V.

MRUS

$6.83B

Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTM

$6.06B

What is the latest ABVX filing?

The latest filing shown is 6-K dated Jun 2, 2026.

How many recent filings does ABVX have?

Intrinsic Alpha currently shows 20 recent filings for ABVX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.